13F Holdings
中文EN

ALGN ALIGN TECHNOLOGY INC

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1097149 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.4%
TTM net income YoY30.0%
TTM EPS YoY32.9%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR10.7%

Margins

Gross margin69.1%
Operating margin14.9%
Net margin11.8%
FCF margin14.5%
EBITDA margin20.6%

Returns

ROE11.9%
ROA7.7%
ROIC (approx.)15.5%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets34.0%
Debt / equity0.00x
Current ratio1.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.52x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$4.03B$4.00B$3.86B$3.73B$3.95B
Cost of revenue$1.32B$1.20B$1.16B$1.10B$1.02B
Gross profit$2.71B$2.80B$2.71B$2.63B$2.94B
R&D expense$369.91M$364.20M$346.83M$305.26M$250.31M
SG&A expense$1.76B$1.76B$1.70B$1.67B$1.71B
Operating income$545.75M$607.63M$643.34M$642.60M$976.40M
Pretax income$585.29M$608.96M$641.20M$599.06M$1.01B
Income tax$174.94M$187.60M$196.15M$237.48M$240.40M
Net income$410.35M$421.36M$445.05M$361.57M$772.02M
EBITDA$783.19M$752.66M$785.74M$768.39M$1.09B
EPS (basic)5.665.635.824.629.78
EPS (diluted)5.655.625.814.619.69
Weighted avg. shares (diluted)72.59M74.99M76.57M78.42M79.67M
Balance sheet
Cash & equivalents$1.09B$1.04B$938.52M$942.36M$1.10B
Short-term investments—$0$35.30M$57.53M$71.97M
Receivables$1.10B$995.68M$903.42M$859.68M$897.20M
Inventory$226.34M$254.29M$296.90M$338.75M$230.23M
Current assets$2.62B$2.49B$2.45B$2.42B$2.49B
PP&E, net$1.13B$1.27B$1.29B$1.23B$1.08B
Goodwill$491.83M$442.63M$419.53M$407.55M$418.55M
Intangibles$93.93M$103.49M$82.12M$95.72M$109.71M
Total assets$6.23B$6.21B$6.08B$5.95B$5.94B
Current liabilities$1.92B$2.04B$2.07B$1.93B$1.92B
Total liabilities$2.18B$2.36B$2.45B$2.35B$2.32B
Shareholders' equity$4.05B$3.85B$3.63B$3.60B$3.62B
Shares outstanding71.36M73.85M75.08M77.27M78.71M
Cash flow statement
Operating cash flow$593.22M$738.23M$785.78M$568.73M$1.17B
Capital expenditure$102.44M$115.58M$177.72M$291.90M$401.10M
Free cash flow$490.78M$622.65M$608.06M$276.83M$771.45M
Investing cash flow-$112.44M-$254.91M-$195.94M-$213.32M-$563.43M
Financing cash flow-$464.58M-$355.72M-$598.34M-$501.69M-$458.33M
Depreciation & amortization$237.44M$145.03M$142.40M$125.79M$108.73M
Stock-based compensation$185.87M$173.70M$154.03M$133.37M$114.34M
Share buybacks$465.94M$352.88M$592.36M$435.04M$375.04M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.